{"doi":"10.1002\/(ISSN)1099-1387","coreId":"9061","oai":"oai:centaur.reading.ac.uk:16478","identifiers":["oai:centaur.reading.ac.uk:16478","10.1002\/(ISSN)1099-1387"],"title":"A \u03b2-amino acid modified heptapeptide containing a designed recognition element disrupts fibrillization of the amyloid \u03b2-peptide","authors":["Castelletto, Valeria","Hamley, Ian W.","Lim, Teck","De Tullio, Matias B.","Casta\u00f1o, Eduardo M."],"enrichments":{"references":[],"documentType":{"type":null}},"contributors":[],"datePublished":"2010-09","abstract":"We study the complex formation of a peptide betaAbetaAKLVFF, previously developed by our group, with Abeta(1\u201342) in aqueous\\ud\nsolution. Circular dichroism spectroscopy is used to probe the interactions between betaAbetaAKLVFF and Abeta(1\u201342), and to study\\ud\nthe secondary structure of the species in solution. Thioflavin T fluorescence spectroscopy shows that the population of\\ud\nfibers is higher in betaAbetaAKLVFF\/Abeta(1\u201342) mixtures compared to pure Abeta(1\u201342) solutions. TEM and cryo-TEM demonstrate\\ud\nthat co-incubation of betaAbetaAKLVFF with Abeta(1\u201342) causes the formation of extended dense networks of branched fibrils, very\\ud\ndifferent from the straight fibrils observed for Abeta(1\u201342) alone. Neurotoxicity assays show that although betaAbetaAKLVFF alters the\\ud\nfibrillization of Abeta(1\u201342), it does not decrease the neurotoxicity, which suggests that toxic oligomeric Abeta(1\u201342) species are still\\ud\npresent in the betaAbetaAKLVFF\/Abeta(1\u201342) mixtures. Our results show that our designed peptide binds to Abeta(1\u201342) and changes the\\ud\namyloid fibril morphology. This is shown to not necessarily translate into reduced toxicity.\\u","downloadUrl":"","fullTextIdentifier":null,"pdfHashValue":null,"publisher":"European Peptide Society and John Wiley & Sons","rawRecordXml":"<record><header><identifier>\n    \n    \n      oai:centaur.reading.ac.uk:16478<\/identifier><datestamp>\n      2017-12-04T03:31:58Z<\/datestamp><setSpec>\n      7374617475733D707562<\/setSpec><setSpec>\n      74797065733D61727469636C65<\/setSpec><setSpec>\n      6469766973696F6E733D315F3965653563346331:335F3134316638303032:355F3838663637316539<\/setSpec><\/header><metadata><rioxx xmlns=\"http:\/\/www.rioxx.net\/schema\/v2.0\/rioxx\/\" xmlns:ali=\"http:\/\/ali.niso.org\/2014\/ali\/1.0\" xmlns:dc=\"http:\/\/purl.org\/dc\/elements\/1.1\/\" xmlns:dcterms=\"http:\/\/purl.org\/dc\/terms\/\" xmlns:rioxxterms=\"http:\/\/docs.rioxx.net\/schema\/v2.0\/rioxxterms\/\" xmlns:xsi=\"http:\/\/www.w3.org\/2001\/XMLSchema-instance\" xsi:schemaLocation=\"http:\/\/www.rioxx.net\/schema\/v2.0\/rioxx\/ http:\/\/www.rioxx.net\/schema\/v2.0\/rioxx\/rioxx.xsd\" ><dc:description>\n    \n      We study the complex formation of a peptide betaAbetaAKLVFF, previously developed by our group, with Abeta(1\u201342) in aqueous\\ud\nsolution. Circular dichroism spectroscopy is used to probe the interactions between betaAbetaAKLVFF and Abeta(1\u201342), and to study\\ud\nthe secondary structure of the species in solution. Thioflavin T fluorescence spectroscopy shows that the population of\\ud\nfibers is higher in betaAbetaAKLVFF\/Abeta(1\u201342) mixtures compared to pure Abeta(1\u201342) solutions. TEM and cryo-TEM demonstrate\\ud\nthat co-incubation of betaAbetaAKLVFF with Abeta(1\u201342) causes the formation of extended dense networks of branched fibrils, very\\ud\ndifferent from the straight fibrils observed for Abeta(1\u201342) alone. Neurotoxicity assays show that although betaAbetaAKLVFF alters the\\ud\nfibrillization of Abeta(1\u201342), it does not decrease the neurotoxicity, which suggests that toxic oligomeric Abeta(1\u201342) species are still\\ud\npresent in the betaAbetaAKLVFF\/Abeta(1\u201342) mixtures. Our results show that our designed peptide binds to Abeta(1\u201342) and changes the\\ud\namyloid fibril morphology. This is shown to not necessarily translate into reduced toxicity.\\ud\n<\/dc:description><dc:language>en<\/dc:language><dc:publisher>European Peptide Society and John Wiley & Sons<\/dc:publisher><dc:relation>http:\/\/www.reading.ac.uk\/chemistry\/about\/staff\/i-w-hamley.aspx<\/dc:relation><dc:relation>http:\/\/onlinelibrary.wiley.com\/journal\/10.1002\/(ISSN)1099-1387<\/dc:relation><dc:source>1099-1387<\/dc:source><dc:title>A \u03b2-amino acid modified heptapeptide containing a designed recognition element disrupts fibrillization of the amyloid \u03b2-peptide<\/dc:title><rioxxterms:author>Castelletto, Valeria<\/rioxxterms:author><rioxxterms:author>Hamley, Ian W.<\/rioxxterms:author><rioxxterms:author>Lim, Teck<\/rioxxterms:author><rioxxterms:author>De Tullio, Matias B.<\/rioxxterms:author><rioxxterms:author>Casta\u00f1o, Eduardo M.<\/rioxxterms:author><rioxxterms:publication_date>2010-09<\/rioxxterms:publication_date><rioxxterms:type>Journal Article\/Review<\/rioxxterms:type><rioxxterms:version>NA<\/rioxxterms:version><rioxxterms:version_of_record>http:\/\/dx.doi.org\/10.1002\/psc.1271<\/rioxxterms:version_of_record><\/rioxx><\/metadata><\/record>","journals":null,"language":null,"relations":["http:\/\/www.reading.ac.uk\/chemistry\/about\/staff\/i-w-hamley.aspx","http:\/\/onlinelibrary.wiley.com\/journal\/10.1002\/(ISSN)1099-1387"],"year":2010,"topics":[],"subject":[],"fullText":null}